Short Peptides Protect Oral Stem Cells from Ageing
Bruna Sinjari1, Francesca Diomede1, Vladimir Khavinson2,3,4
1Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy.
Abstract:
Primary stem cells, after several cell divisions, enter into a senescence state, that is characterized by alterations to spindle-shape typical morphology. This concern is one of the main problems in the use of human mesenchymal stem cells (hMSCs) in clinical applications which demand cells in large numbers. Short peptides had geroprotective properties and stimulated stem cell differentiation. The aim of the study is to demonstrate the role of AEDG and KED peptides in maintaining oral hMSCs morphology and functions over long-term expansion. 2 types of hMSCs were investigated: human periodontal ligament stem cells (hPLSCs) and human gingival mesenchymal stem cells (hGMSCs). Cells at the 25th passage were divided into 3 groups: 1 - control (without adding peptide), 2 - treated with AEDG peptide, 3 - treated with KED peptide. Cell cultures were analyzed by an immunofluorescence method and RT-PCR on the p16 and p21 senescence markers expression. AEDG peptide decreased p16 and p21 mRNA expression by 1.56-2.44 times in comparison with the control group. KED peptide decreased p16 and p21 mRNA expression by 1.82-3.23 times in comparison with the control group. These results were confirmed by immunofluorescent visualization. AEDG and KED peptides could be used as supplementary substances in a culture medium to delay the expression of senescence markers in long term stem cell cultivation in order to promote the large-scale in vitro expansion necessarily required for stem cell therapy clinical application. The data obtained confirm the geroprotective effect of AEDG and KED peptide, which was shown early in animal and cells models.
Insights
Short peptides AEDG and KED delay senescence in human mesenchymal stem cells (hMSCs). These findings support using peptides to maintain hMSC morphology and function for clinical applications requiring large cell numbers.
Area of Science:
- Stem Cell Biology
- Gerontology
- Biotechnology
Background:
- Primary stem cells, including human mesenchymal stem cells (hMSCs), enter senescence after prolonged division, altering morphology and limiting clinical use.
- Senescence in hMSCs poses a significant challenge for cell therapies requiring large cell quantities.
- Short peptides have demonstrated geroprotective effects and the ability to stimulate stem cell differentiation.
Purpose of the Study:
- To investigate the role of AEDG and KED peptides in preserving the morphology and function of oral hMSCs during long-term expansion.
- To evaluate the potential of these peptides to mitigate senescence in cultured hMSCs.
Main Methods:
- Two types of oral hMSCs, human periodontal ligament stem cells (hPLSCs) and human gingival mesenchymal stem cells (hGMSCs), were cultured.
- Cells at passage 25 were divided into control, AEDG peptide-treated, and KED peptide-treated groups.
- Senescence markers (p16 and p21) expression was analyzed using RT-PCR and immunofluorescence.
Main Results:
- AEDG peptide treatment reduced p16 and p21 mRNA expression by 1.56-2.44 times compared to controls.
- KED peptide treatment reduced p16 and p21 mRNA expression by 1.82-3.23 times compared to controls.
- Immunofluorescence confirmed the reduced expression of senescence markers in peptide-treated groups.
Conclusions:
- AEDG and KED peptides exhibit geroprotective effects, delaying senescence marker expression in long-term hMSC cultures.
- These peptides can be utilized as supplementary agents in culture media to support large-scale in vitro expansion of hMSCs.
- The findings support the clinical application of stem cell therapy by enabling the necessary expansion of functional cells.
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Niche
Renewal of Intestinal Stem Cells
Clinical Applications of Epidermal Stem Cells
Multipotency of Hematopoietic Stem Cells


